Castro Valley, CA, United States of America

Ching-Wen Hsiao

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Acepodia, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ching-Wen Hsiao. Retrieved from https://idiyas.com/inventor/ching-wen-hsiao-k901q82e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Ching-Wen Hsiao

Introduction

Ching-Wen Hsiao is an accomplished inventor based in Castro Valley, CA (US). He has made significant contributions to the field of biological complexes and their applications in therapeutics. His work focuses on improving modalities for targeting therapeutics, particularly in immunotherapy.

Latest Patents

Ching-Wen Hsiao holds 1 patent titled "Biological complexes and methods for using same." This patent discloses complexes that comprise targeting units, methods for their production, and methods for their use. In some embodiments, these complexes include therapeutic agents complexed with targeting units, as well as cells complexed with targeting units. The invention addresses the need for improved targeting modalities in therapeutics.

Career Highlights

Ching-Wen Hsiao is currently associated with Acepodia, Inc., where he continues to innovate in the field of biological complexes. His work has the potential to advance therapeutic strategies and improve patient outcomes.

Collaborations

Ching-Wen has collaborated with notable colleagues, including Amy A. Twite and Sonny Hsiao, who contribute to the innovative environment at Acepodia, Inc.

Conclusion

Ching-Wen Hsiao's contributions to the field of biological complexes demonstrate his commitment to advancing therapeutic modalities. His innovative work is paving the way for future developments in immunotherapy and related areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…